Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154283 | SCV000203942 | drug response | Tyrosine kinase inhibitor response | 2011-11-07 | criteria provided, single submitter | clinical testing | |
Key Laboratory of Carcinogenesis and Cancer Invasion, |
RCV003998245 | SCV004042731 | likely pathogenic | Lung adenocarcinoma | no assertion criteria provided | clinical testing |